Back to Search

BAYARD CLARKSON, MD

MD

Psychiatry Physician

NPI: 1669463956Individual

Specialties, Licenses & Credentials

Psychiatry PhysicianPrimary

Psychiatry & Neurology — Psychiatry

Code: 2084P0800X

53344(MA)
Child & Adolescent Psychiatry Physician

Psychiatry & Neurology — Child & Adolescent Psychiatry

Code: 2084P0804X

53344(MA)

Research & Publications (20)

Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies.
PMID 12835715·Leukemia·2003
6-review
The questionable benefit of multiple free-flow studies in men with lower urinary tract symptoms.
PMID 19012300·Neurourol Urodyn·2009
8-other
The effect of the surface characteristics of various substrates on fluorapatite crystal growth, alignment, and spatial orientation.
PMID 19478709·Med Sci Monit·2009
8-other
Fibronectin adsorption studied using neutron reflectometry and complementary techniques.
PMID 19551415·Eur Phys J E Soft Matter·2009
8-other
Multisite evaluation of noninvasive bladder pressure flow recording using the penile cuff device: assessment of test-retest agreement.
PMID 18930484·J Urol·2008
4-observational
Change.
PMID 18502957·J Dent Res·2008
8-other
A solid-phase Bcr-Abl kinase assay in 96-well hydrogel plates.
PMID 18194660·Anal Biochem·2008
8-other
L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.
PMID 17372901·Int J Cancer·2007
7-preclinical
Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor.
PMID 17699867·Clin Cancer Res·2007
7-preclinical
Synthesis and biological evaluation of a fluorine-18 derivative of dasatinib.
PMID 17956080·J Med Chem·2007
7-preclinical
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.
PMID 18060032·J Clin Invest·2007
7-preclinical
Quantification of change in phosphorylation of BCR-ABL kinase and its substrates in response to Imatinib treatment in human chronic myelogenous leukemia cells.
PMID 16858728·Proteomics·2006
8-other
Effects of systemic fluoride and in vitro fluoride treatment on enamel crystals.
PMID 17062747·J Dent Res·2006
7-preclinical
Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance.
PMID 16754879·Proc Natl Acad Sci U S A·2006
8-other
Synthesis of a potentially bioactive, hydroxyapatite-nucleating molecule.
PMID 16397739·Calcif Tissue Int·2006
8-other
Induced fit and "lock and key" recognition of 5S RNA by zinc fingers of transcription factor IIIA.
PMID 16405997·J Mol Biol·2006
7-preclinical
Myosin light chain kinase A is activated by cGMP-dependent and cGMP-independent pathways.
PMID 16546177·FEBS Lett·2006
7-preclinical
Loss of p53 impedes the antileukemic response to BCR-ABL inhibition.
PMID 16651519·Proc Natl Acad Sci U S A·2006
7-preclinical
Dentin-pulp complex responses to carious lesions.
PMID 16707876·Caries Res·2006
7-preclinical
Synthesis of Fluorapatite Nanorods and Nanowires by Direct Precipitation from Solution.
PMID 19513184·Cryst Growth Des·2006
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
47 CRAFTS RD
CHESTNUT HILL, MA 02467

Location

Practice Location

47 CRAFTS RD, CHESTNUT HILL, MA
(617) 730-8174

Quick Facts

NPI
1669463956
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile